Literature DB >> 15534048

Metabolic rates in small brain nuclei determined by high-resolution PET.

Wolf-Dieter Heiss1, Birgit Habedank, Johannes Christian Klein, Karl Herholz, Klaus Wienhard, Mark Lenox, Ron Nutt.   

Abstract

UNLABELLED: Identification of small nuclei in the brain by PET has been limited by the spatial resolution of conventional scanners. The new detector technology and advanced signal analysis of a high-resolution research tomograph (HRRT) has improved 3-dimensional spatial resolution to 2.2 mm at sufficient efficiency and permitted the quantification of tracer concentrations in small volumes.
METHODS: In 9 healthy volunteers, cerebral glucose metabolism was investigated after intravenous injection of 370 MBq of (18)F-FDG, and regional cerebral metabolic rates for glucose (rCMRGlc) were determined in various structures of the brain identified on coregistered MR images using stereotactic and topographic anatomic information.
RESULTS: rCMRGlc values (in mumol/100 g/min) were higher in the cerebral cortex (33.5 +/- 2.98), the basal ganglia (32.6 +/- 3.04 in the nucleus caudatus and 40.2 +/- 3.50 in the putamen), the thalamus (36.6 +/- 4.72), and the cerebellum (29.8 +/- 2.20) and were lower in the cerebral white matter (12.3 +/- 1.45) than those reported previously with conventional scanners. This resulted in an increased ratio of cortical values to white-matter values. Various nuclei in the basal frontal lobe (21.4 +/- 3.19 in the basal forebrain and 32.3 +/- 2.39 in the nucleus accumbens), the temporal lobe (22.2 +/- 1.74 in the corpus amygdalae), the hippocampus (25.7 +/- 2.11), the diencephalon (23.1 +/- 3.33 in the corpus geniculatum laterale, 20.2 +/- 2.87 in the corpus geniculatum mediale, and 25.2 +/- 3.29 in the nucleus subthalamicus), and the brain stem (24.4 +/- 2.47 in the colliculus superior, 31.4 +/- 3.63 in the colliculus inferior, 31.0 +/- 3.10 in the nucleus ruber, and 22.8 +/- 2.35 in the substantia nigra) could be identified, and the metabolic rate was assessed in these structures. The effect of improved spatial resolution on quantified metabolic rates could directly be demonstrated in a few cases investigated on scanners of different generations.
CONCLUSION: The improved spatial resolution of the HRRT decreased partial-volume effects in the quantification of metabolic rates in the brain and increased the accuracy of rCMRGlc values in large structures. For the first time, this scanner has permitted the determination of metabolic rates in small nuclei that are involved in various neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15534048

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  23 in total

Review 1.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

2.  Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.

Authors:  Andrea Varrone; Nils Sjöholm; Lars Eriksson; Balazs Gulyás; Christer Halldin; Lars Farde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-13       Impact factor: 9.236

3.  Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.

Authors:  Kati Alakurtti; Sargo Aalto; Jarkko J Johansson; Kjell Någren; Terhi Tuokkola; Vesa Oikonen; Matti Laine; Juha O Rinne
Journal:  J Cereb Blood Flow Metab       Date:  2010-05-05       Impact factor: 6.200

4.  Comparison of HRRT and HR+ scanners for quantitative (R)-[11C]verapamil, [11C]raclopride and [11C]flumazenil brain studies.

Authors:  Floris H P van Velden; Syahir M Mansor; Daniëlle M E van Assema; Bart N M van Berckel; Femke E Froklage; Shaonan Wang; Robert C Schuit; Marie-Claude Asselin; Adriaan A Lammertsma; Ronald Boellaard; Marc C Huisman
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

5.  Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.

Authors:  Eero Rissanen; Jouni Tuisku; Pauliina Luoto; Eveliina Arponen; Jarkko Johansson; Vesa Oikonen; Riitta Parkkola; Laura Airas; Juha O Rinne
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-05       Impact factor: 6.200

6.  Multimodal quantitative magnetic resonance imaging of thalamic development and aging across the human lifespan: implications to neurodegeneration in multiple sclerosis.

Authors:  Khader M Hasan; Indika S Walimuni; Humaira Abid; Richard E Frye; Linda Ewing-Cobbs; Jerry S Wolinsky; Ponnada A Narayana
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

7.  Hyperglycaemia is associated with changes in the regional concentrations of glucose and myo-inositol within the brain.

Authors:  O Heikkilä; N Lundbom; M Timonen; P-H Groop; S Heikkinen; S Mäkimattila
Journal:  Diabetologia       Date:  2008-12-19       Impact factor: 10.122

Review 8.  In-vivo human brain molecular imaging with a brain-dedicated PET/MRI system.

Authors:  Zang Hee Cho; Young Don Son; Eun Jung Choi; Hang Keun Kim; Jeong Hee Kim; Sang Yoon Lee; Seiji Ogawa; Young Bo Kim
Journal:  MAGMA       Date:  2012-08-03       Impact factor: 2.310

9.  Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.

Authors:  Eero Rissanen; Jere R Virta; Teemu Paavilainen; Jouni Tuisku; Semi Helin; Pauliina Luoto; Riitta Parkkola; Juha O Rinne; Laura Airas
Journal:  J Cereb Blood Flow Metab       Date:  2013-05-22       Impact factor: 6.200

Review 10.  [Positron emission tomography in pain research. From the structure to the activity of the opiate receptor system].

Authors:  T Sprenger; G Henriksen; M Valet; S Platzer; A Berthele; T R Tölle
Journal:  Schmerz       Date:  2007-11       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.